Cresco Labs Inc. (OTCMKTS:CRLBF - Get Free Report) saw a large drop in short interest in the month of December. As of December 15th, there was short interest totalling 726,100 shares, a drop of 9.8% from the November 30th total of 805,300 shares. Based on an average daily volume of 1,814,600 shares, the days-to-cover ratio is presently 0.4 days.
Cresco Labs Stock Down 3.4 %
Cresco Labs stock traded down $0.03 during midday trading on Monday, hitting $0.82. 1,199,032 shares of the stock were exchanged, compared to its average volume of 773,379. Cresco Labs has a 1 year low of $0.79 and a 1 year high of $2.65. The company has a debt-to-equity ratio of 1.80, a current ratio of 1.97 and a quick ratio of 1.39. The firm has a market cap of $400.52 million, a P/E ratio of -4.10 and a beta of 1.73. The company has a 50 day moving average price of $1.19 and a two-hundred day moving average price of $1.49.
Wall Street Analysts Forecast Growth
A number of analysts have recently issued reports on CRLBF shares. Cormark cut Cresco Labs from a "moderate buy" rating to a "hold" rating in a report on Monday, November 11th. Roth Capital upgraded shares of Cresco Labs to a "strong-buy" rating in a research note on Sunday, November 10th. Finally, Atb Cap Markets downgraded shares of Cresco Labs from a "strong-buy" rating to a "hold" rating in a research note on Monday, December 9th. Four analysts have rated the stock with a hold rating, two have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $2.50.
View Our Latest Research Report on Cresco Labs
About Cresco Labs
(
Get Free Report)
Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cresco Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cresco Labs wasn't on the list.
While Cresco Labs currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.